Annual Revenue
$289.21 M
-$329.75 M-53.27%
31 December 2023
Summary:
Fulgent Genetics annual revenue is currently $289.21 million, with the most recent change of -$329.75 million (-53.27%) on 31 December 2023. During the last 3 years, it has fallen by -$132.50 million (-31.42%). FLGT annual revenue is now -70.86% below its all-time high of $992.58 million, reached on 31 December 2021.FLGT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$71.74 M
+$715.00 K+1.01%
30 September 2024
Summary:
Fulgent Genetics quarterly revenue is currently $71.74 million, with the most recent change of +$715.00 thousand (+1.01%) on 30 September 2024. Over the past year, it has dropped by -$12.94 million (-15.28%). FLGT quarterly revenue is now -80.04% below its all-time high of $359.43 million, reached on 31 March 2021.FLGT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$277.76 M
-$12.94 M-4.45%
30 September 2024
Summary:
Fulgent Genetics TTM revenue is currently $277.76 million, with the most recent change of -$12.94 million (-4.45%) on 30 September 2024. Over the past year, it has dropped by -$8.65 million (-3.02%). FLGT TTM revenue is now -73.19% below its all-time high of $1.04 billion, reached on 30 September 2021.FLGT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.3% | -15.3% | -3.0% |
| 3 y3 years | -31.4% | -68.5% | -73.2% |
| 5 y5 years | +1254.6% | +593.4% | +831.6% |
FLGT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -70.9% | at low | -77.6% | +11.3% | -73.2% | at low |
| 5 y | 5 years | -70.9% | +1254.6% | -80.0% | +825.4% | -73.2% | +831.6% |
| alltime | all time | -70.9% | >+9999.0% | -80.0% | +2373.0% | -73.2% | +9461.5% |
Fulgent Genetics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $71.74 M(+1.0%) | $277.76 M(-4.5%) |
| June 2024 | - | $71.03 M(+10.1%) | $290.70 M(+1.1%) |
| Mar 2024 | - | $64.48 M(-8.5%) | $287.53 M(-0.6%) |
| Dec 2023 | $289.21 M(-53.3%) | $70.50 M(-16.7%) | $289.21 M(+1.0%) |
| Sept 2023 | - | $84.69 M(+24.8%) | $286.41 M(-6.8%) |
| June 2023 | - | $67.85 M(+2.5%) | $307.38 M(-15.8%) |
| Mar 2023 | - | $66.17 M(-2.3%) | $364.87 M(-41.1%) |
| Dec 2022 | $618.97 M(-37.6%) | $67.70 M(-35.9%) | $618.97 M(-22.9%) |
| Sept 2022 | - | $105.66 M(-15.7%) | $802.93 M(-13.2%) |
| June 2022 | - | $125.34 M(-60.9%) | $925.15 M(-3.0%) |
| Mar 2022 | - | $320.27 M(+27.3%) | $953.42 M(-3.9%) |
| Dec 2021 | $992.58 M(+135.4%) | $251.67 M(+10.4%) | $992.58 M(-4.2%) |
| Sept 2021 | - | $227.87 M(+48.3%) | $1.04 B(+13.9%) |
| June 2021 | - | $153.62 M(-57.3%) | $909.74 M(+17.6%) |
| Mar 2021 | - | $359.43 M(+21.8%) | $773.39 M(+83.4%) |
| Dec 2020 | $421.71 M(+1196.5%) | $294.98 M(+190.0%) | $421.71 M(+212.1%) |
| Sept 2020 | - | $101.72 M(+489.1%) | $135.12 M(+208.8%) |
| June 2020 | - | $17.27 M(+122.7%) | $43.75 M(+25.3%) |
| Mar 2020 | - | $7.75 M(-7.6%) | $34.91 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $32.53 M(+52.3%) | $8.39 M(-18.9%) | $32.53 M(+9.1%) |
| Sept 2019 | - | $10.35 M(+22.8%) | $29.81 M(+18.8%) |
| June 2019 | - | $8.42 M(+56.9%) | $25.09 M(+13.7%) |
| Mar 2019 | - | $5.37 M(-5.3%) | $22.07 M(+3.4%) |
| Dec 2018 | $21.35 M(+14.0%) | $5.67 M(+0.9%) | $21.35 M(+7.0%) |
| Sept 2018 | - | $5.63 M(+4.2%) | $19.96 M(+6.0%) |
| June 2018 | - | $5.40 M(+16.1%) | $18.84 M(+4.2%) |
| Mar 2018 | - | $4.65 M(+8.7%) | $18.08 M(-3.5%) |
| Dec 2017 | $18.73 M(+2.5%) | $4.28 M(-4.9%) | $18.73 M(-7.7%) |
| Sept 2017 | - | $4.50 M(-3.0%) | $20.30 M(-2.4%) |
| June 2017 | - | $4.64 M(-12.6%) | $20.81 M(+3.3%) |
| Mar 2017 | - | $5.31 M(-9.4%) | $20.14 M(+10.2%) |
| Dec 2016 | $18.28 M(+90.9%) | $5.85 M(+16.8%) | $18.28 M(+19.3%) |
| Sept 2016 | - | $5.01 M(+26.2%) | $15.32 M(+15.9%) |
| June 2016 | - | $3.97 M(+15.4%) | $13.22 M(+42.9%) |
| Mar 2016 | - | $3.44 M(+18.6%) | $9.25 M(+59.2%) |
| Dec 2015 | $9.58 M(+649.3%) | $2.90 M(-0.1%) | $5.81 M(+99.9%) |
| Sept 2015 | - | $2.90 M | $2.90 M |
| Dec 2014 | $1.28 M | - | - |
FAQ
- What is Fulgent Genetics annual revenue?
- What is the all time high annual revenue for Fulgent Genetics?
- What is Fulgent Genetics annual revenue year-on-year change?
- What is Fulgent Genetics quarterly revenue?
- What is the all time high quarterly revenue for Fulgent Genetics?
- What is Fulgent Genetics quarterly revenue year-on-year change?
- What is Fulgent Genetics TTM revenue?
- What is the all time high TTM revenue for Fulgent Genetics?
- What is Fulgent Genetics TTM revenue year-on-year change?
What is Fulgent Genetics annual revenue?
The current annual revenue of FLGT is $289.21 M
What is the all time high annual revenue for Fulgent Genetics?
Fulgent Genetics all-time high annual revenue is $992.58 M
What is Fulgent Genetics annual revenue year-on-year change?
Over the past year, FLGT annual revenue has changed by -$329.75 M (-53.27%)
What is Fulgent Genetics quarterly revenue?
The current quarterly revenue of FLGT is $71.74 M
What is the all time high quarterly revenue for Fulgent Genetics?
Fulgent Genetics all-time high quarterly revenue is $359.43 M
What is Fulgent Genetics quarterly revenue year-on-year change?
Over the past year, FLGT quarterly revenue has changed by -$12.94 M (-15.28%)
What is Fulgent Genetics TTM revenue?
The current TTM revenue of FLGT is $277.76 M
What is the all time high TTM revenue for Fulgent Genetics?
Fulgent Genetics all-time high TTM revenue is $1.04 B
What is Fulgent Genetics TTM revenue year-on-year change?
Over the past year, FLGT TTM revenue has changed by -$8.65 M (-3.02%)